Henry E. Chang is a senior leader with over 30 years of experience advancing global health, humanitarian relief, public-private partnerships, and patient advocacy. He currently serves as Executive Director of the Fatty Liver Foundation, where he champions liver health equity and patient-centered innovation. His career spans leadership roles in non-profits, government research, life sciences, and healthcare consulting, including positions at the Global Business Coalition on HIV/AIDS, Tuberculosis, and Malaria, Doctors of the World USA, AIDS Healthcare Foundation, the U.S. National Institute of Allergy and Infectious Diseases, DuPont Merck Pharmaceutical Company, and Health Business Solutions.

Henry is a patient representative on the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines Committee and serves on the boards of Hep Free NYC and the Touch of Hope Foundation in India. He attended a PhD program at UCLA, where he also completed a clinical research fellowship in infectious diseases at Cedars-Sinai Medical Center.